Extended-release calcifediol for secondary hyperparathyroidism in stage 3-4 chronic kidney disease
نویسندگان
چکیده
منابع مشابه
Secondary hyperparathyroidism in chronic kidney disease
Chronic kidney failure is much more common than people realize, and often goes undetected and undiagnosed until the disease is well advanced and k function decreases it affects many other systems of the body mainly the calcium phosphorous metabolism as the metabolism is mainly controlled by kidney in terms of absor of calcium phosphorus. Secondary hyperparathyroidism is usually found in patient...
متن کاملPrevalence of secondary hyperparathyroidism in patients with stage 3 and 4 chronic kidney disease seen in internal medicine.
OBJECTIVE Despite the high prevalence of chronic kidney disease in the elderly population, few data are available on the frequency of secondary hyperparathyroidism in the Spanish population affected by this problem. We undertook a study on this issue in patients attending the internal medicine departments in our area. DESIGN AND METHODS An observational, cross-sectional survey performed at in...
متن کاملSecondary Hyperparathyroidism and Chronic Kidney Disease
19 ro m R esarch to P ratice / D ab tic K id ey D isase Secondary hyperparathyroidism (SHPT) describes a complex alteration in bone and mineral metabolism that occurs as a direct result of chronic kidney disease (CKD). Bone disease, a well-recognized complication of SHPT, represents only a small concern in light of the evidence that correlates SHPT with cardiovascular disease and an increased r...
متن کاملParicalcitol Versus Calcifediol for Treating Hyperparathyroidism in Kidney Transplant Recipients
Introduction Secondary hyperparathyroidism (SHPT) and vitamin D deficiency are common at kidney transplantation and are associated with some early and late complications. This study was designed to evaluate whether paricalcitol was more effective than nutritional vitamin D for controlling SHPT in de novo kidney allograft recipients. Methods This was a 6-month, investigator-initiated, multicen...
متن کاملSerum triglycerides and risk for death in Stage 3 and Stage 4 chronic kidney disease.
BACKGROUND An elevated triglyceride level is associated with cardiovascular and all-cause mortality in the general population. The associations between serum triglyceride and all-cause mortality among patients with chronic kidney disease (CKD) are unclear. METHODS Patients with Stage 3 and Stage 4 CKD (estimated glomerular filtration rate 15-59 mL/min/1.73 m(2)) who had serum triglycerides me...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Expert Review of Endocrinology & Metabolism
سال: 2017
ISSN: 1744-6651,1744-8417
DOI: 10.1080/17446651.2017.1347501